Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36403579

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2023 Jan
First author
Herrera AF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2023 Jan;10(1):e2-e3. doi: 10.1016/S2352-3026(22)00332-5.
    note
    Source null
    related pmid
    36566047
    relationship
    Comment in

Authors and identifiers

  1. name
    Herrera AF
    type
    Author
  2. name
    Chen L
    type
    Author
  3. name
    Nieto Y
    type
    Author
  4. name
    Holmberg L
    type
    Author
  5. name
    Johnston P
    type
    Author
  6. name
    Mei M
    type
    Author
  7. name
    Popplewell L
    type
    Author
  8. name
    Armenian S
    type
    Author
  9. name
    Cao T
    type
    Author
  10. name
    Farol L
    type
    Author
  11. name
    Sahebi F
    type
    Author
  12. name
    Spielberger R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Herrera AF
    type
    Author
  2. name
    Chen L
    type
    Author
  3. name
    Nieto Y
    type
    Author
  4. name
    Holmberg L
    type
    Author
  5. name
    Johnston P
    type
    Author
  6. name
    Mei M
    type
    Author
  7. name
    Popplewell L
    type
    Author
  8. name
    Armenian S
    type
    Author
  9. name
    Cao T
    type
    Author
  10. name
    Farol L
    type
    Author
  11. name
    Sahebi F
    type
    Author
  12. name
    Spielberger R
    type
    Author
bibliography ids
  1. nci-bib-6ba5f0e6b9d9b6dc253ebd37
book metadata
content sha256
b77385ab3fd341615dd26d25193010687c4d747354a73b636080d6935c79860f
document type
citation
dois
  1. 10.1016/S2352-3026(22)00318-0
electronic publication date
display
2022 Nov 17
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36403579
immutable id
pubmed:36403579@b77385ab3fd341615dd26d25193010687c4d747354a73b636080d6935c79860f
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
1
name
The Lancet. Haematology
nlm unique id
101643584
pages
e14-e23
volume
10
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2023 Jan;10(1):e2-e3. doi: 10.1016/S2352-3026(22)00332-5.
    note
    Source null
    related pmid
    36566047
    relationship
    Comment in
outcomes validated
false
pmid
36403579
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
23b834e6693aa6284a67cea8b07128a2d1bc434a56f7af22a810d8d5bfe278f0
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Jan
precision
month
year
2023
publication types
  1. Multicenter Study
  2. Clinical Trial, Phase II
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36403579/
title
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.

Preserved source evidence · Not medical advice